Noel J. Guillama-Alvarez
It didn’t take long for President Trump to make his mark. He signed more than 20 executive orders in a single sitting, with multiple sessions to follow. If you visit the White House website (link below), you can find six pages of executive orders, many bundled with detailed instructions.
47 Takes Immediate Action on Artificial Intelligence (AI)
On AI, things moved fast. President Trump rescinded President Biden’s executive order on AI, issued in October 2023. Let’s recall that, back in February 2019, Trump signed his own executive order making AI a national priority for the U.S., aligned with the National AI Initiative Act of 2020.
Just 24 hours later, Trump announced a groundbreaking $500 billion collaboration between OpenAI, SoftBank, and Oracle to form Stargate, a new initiative. This partnership aims to expand data center capacity to support advanced AI projects, including OpenAI’s vision of creating highly autonomous systems—AI agents that could exceed human capabilities in valuable economic tasks. This ambitious project was presented as a key move to secure America’s leadership in AI, stimulate economic growth, and create hundreds of thousands of jobs.
The initiative kicks off with a $100 billion investment, starting with a 1-million-square-foot data center currently under construction by Oracle in Texas. SoftBank will manage financial operations, with OpenAI taking the lead on technical aspects. Masayoshi Son, CEO of SoftBank, will chair the project. Tech giants like Arm, Microsoft, and Nvidia will collaborate, ensuring cutting-edge innovation. Internationally, the United Arab Emirates’ MGX is also involved, signaling Abu Dhabi’s strategic push into AI.
In his public announcement, Larry Ellison, founder of Oracle, and Sam Altman, CEO of OpenAI/ChatGPT, highlighted AI’s potential in healthcare, particularly in cancer research. AI has already begun making significant strides in personalized cancer treatments, especially using genetic sequencing to match patients with existing drugs that can extend their lives. As of now, over 100 companies, both public and private, are working toward the same goal.
While we’re excited about the massive investments in AI infrastructure, we remain cautious about its large-scale applications in medicine beyond radiology, pathology, and genetics. The road to trust, along with the resolution of legal and ethical challenges, will take time. AI isn’t necessarily faster, cheaper, or more efficient than human doctors—especially when factoring in the time required for data preparation and adjustment. The risks, particularly concerning privacy, are substantial.
Despite these challenges, we continue to believe the best non-research applications of AI lie in areas where input and output can be controlled outside of Large Language Models (LLMs), with a goal of empowering consumers. In healthcare, while cancer is devastating and a focus of AI efforts, let’s not forget the millions of Americans affected by other conditions. For example, 60 million people suffer from hypertension, 50 million from high cholesterol, 50 million from arthritis, 20 million from Type 2 diabetes, and 15 million from COPD and depression. Cancer impacts 12 million.
What would be truly revolutionary is utilizing electronic health records (EHR) to track how the 6.7 billion prescriptions dispensed in 2022 are affecting patients. Many Americans, particularly those over 50, are on multiple prescriptions, with those over 65 averaging three. My own mother, at 86, has 13 prescriptions.
SEC and Crypto
On the same day as Trump’s Stargate announcement, the U.S. Securities and Exchange Commission (SEC) issued a press release titled “SEC Crypto 2.0: Acting Chairman Uyeda Announces Formation of New Crypto Task Force.” As we discussed in a previous blog, major changes are coming to the SEC’s approach to crypto, tokens, and blockchain.
Acting SEC Chairman Mark T. Uyeda announced the creation of a specialized crypto task force, which aims to develop a clear and comprehensive regulatory framework for crypto assets. This marks a significant shift in the SEC’s approach to the rapidly evolving digital asset industry, with an emphasis on proactive policymaking rather than retroactive enforcement.
The task force will be led by Commissioner Hester Peirce, known for her focus on fostering innovation in financial technology. She will be supported by Richard Gabbert as Chief of Staff and Taylor Asher as Chief Policy Advisor. This team will work closely with SEC staff and engage with public stakeholders to create sensible regulations that balance innovation and investor protection.
The initiative will tackle the ambiguity surrounding crypto asset registration requirements that have hindered innovation. By offering clear, actionable guidance, the SEC hopes to create a balanced regulatory environment that promotes responsible innovation while ensuring the integrity of financial markets.
A New Era for Crypto and Healthcare Innovation
This is a time for celebration! The previously hostile stance toward crypto is finally coming to an end. I believe we’ll see tremendous innovation and leadership once clear, reasonable rules are established. We see a convergence of healthcare, AI, and crypto at the crossroads—empowering consumers and putting all of us at the forefront of these dynamic fields. That intersection is symbolized by the X in our OXIO Health® logo.
About HealthScoreAI™
Healthcare is at a tipping point, and HealthScoreAI is positioning to revolutionize the industry by giving consumers control over their health data and unlocking its immense value. U.S. healthcare annual spending has exceeded $5 trillion with little improvement in outcomes. Despite advances, technology has failed to reduce costs or improve care. Meanwhile, 3,000 exabytes of consumer health data remain trapped in fragmented USA systems, leaving consumers and doctors without a complete picture of care.
HealthScoreAI seeks to provide a unique solution, acting as a data surrogate for consumers and offering an unbiased holistic view of their health. By monetizing de-identified data, HealthScoreAI seeks to share revenue with consumers, potentially creating a new $100 billion market opportunity. With near-universal EHR adoption in the USA, and advances in technology, now is the perfect time to capitalize on the data available, practical use of AI and the empowering of consumers, in particular the 13,000 tech savvy baby boomers turning 65 every single day and entering the Medicare system for the first time. Our team, with deep healthcare and tech expertise, holds U.S. patents and a proven track record of scaling companies and leading them to IPO.
Noel J. Guillama-Alvarez
https://www.linkedin.com/in/nguillama/
+1-561-904-9477, Ext 355
https://www.whitehouse.gov/presidential-actions/
https://youtu.be/nFgyDAMdAL0?si=iJtchvi72MR34AjC
https://www.cbsnews.com/news/trump-stargate-ai-openai-softbank-oracle-musk/
https://www.sec.gov/newsroom/press-releases/2025-30